Emcure Pharmaceuticals stock | Expectations for 2026, valuation & analysis

Emcure Pharmaceutica...

NSEI:EMCURE

Rp 1.593,40

Rp0,00 (0,00%)

1.593,40 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

Emcure Pharmaceuticals Stock Value

The current analyst rating for NSEI:EMCURE is Buy.

Buy

Emcure Pharmaceuticals Company Info

EPS Growth 5Y

0,00%

Market Cap

Rp302,09 B

Long-Term Debt

Rp1,90 B

Quarterly earnings

05/22/2026

Dividend

Rp3,03

Dividend Yield

0,19%

Founded

1981

Industry

Health Care

Country

India

Website

Emcure Pharmaceuticals

ISIN Number

INE168P01015

Website

http://www.emcure.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp1.783,50

11.93%

Last Update: 03/28/2026

Analysts: 6

Highest Price Target Rp1.932,00

Average Price Target Rp1.783,50

Lowest Price Target Rp1.620,00

In the last five quarters, Emcure Pharmaceuticals’s Price Target has risen from Rp0,00 to Rp1.593,40 - a 100,00% increase. Five analysts predict that Emcure Pharmaceuticals’s share price will increase in the coming year, reaching Rp1.783,50. This would represent an increase of 11,93%.

Top growth stocks in the health care sector (5Y.)

What does Emcure Pharmaceuticals do?

Emcure Pharmaceuticals Limited is a player in the pharmaceutical industry, engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates with a commitment to providing high-quality healthcare solutions that cater to the diverse needs of patients across various therapeutic areas. The company's portfolio includes a variety of formulations, including injectables, oral solids, and other dosage forms, which are designed to address critical h...

Business Segments

The company operates through several key business segments that encompass a broad spectrum of pharmaceutical products and services. The company's primary segments include:

Formulations

This segment is the backbone of Emcure Pharmaceuticals, comprising a diverse range of pharmaceutical formulations. The company specializes in the production of oral solids, injectables, and other dosage forms that cater to various therapeutic areas, including oncology, cardiology, gynecology, and more.

Active Pharmaceutical Ingredients (APIs)

This segment involves in the manufacturing of active pharmaceutical ingredients, which are essential components in the production of pharmaceutical formulations. The company's expertise in API production allows it to maintain control over the quality and consistency of its products, thereby enhancing its overall product offerings.

Biologics

This segment focuses on the development of innovative biological products that address unmet medical needs. This segment reflects The company's commitment to advancing healthcare through cutting-edge research and development.

Contract Manufacturing

This segment offers contract manufacturing services to other pharmaceutical companies, leveraging its state-of-the-art facilities and expertise in production.

International Operations

This segment establishes a presence in various international markets. The company is dedicated to providing high-quality healthcare solutions globally, adapting its products to meet the specific needs of different regions.

Business Strategy

The company has formulated a comprehensive business strategy aimed at achieving sustainable growth and enhancing its competitive advantage in the pharmaceutical industry. The company's strategy encompasses several key elements:

Innovation and R&D: The company places a strong emphasis on research and development to drive innovation in its product offerings. The company invests significantly in R&D activities to develop new formulations, improve existing products, and explore novel therapeutic areas. This commitment to innovation enables

Quality Assurance: The company is dedicated to maintaining the highest standards of quality in its products. The company adheres to stringent quality control measures throughout the manufacturing process, ensuring that all products meet regulatory requirements and are safe for patient use.

Market Expansion: The company aims to expand its market presence both domestically and internationally. The company actively seeks opportunities to enter new markets and strengthen its distribution networks.

Customer-Centric Approach: The company prioritizes understanding the needs of its customers, including healthcare providers and patients. The company engages in regular communication with stakeholders to gather feedback and insights, which inform product development and marketing strategies.

Sustainability and Compliance: The company is committed to operate in an environmentally responsible manner while complying with all relevant regulations. The company actively seeks to minimize its environmental impact through sustainable practices in manufacturing and operations.

Products and Services

The company offers a comprehensive range of products and services designed to meet the diverse healthcare needs of patients. The company's product portfolio includes:

Pharmaceutical Formulations: The company specializes in the development and manufacturing of various pharmaceutical formulations, including oral solids, injectables, and topical applications. The formulations are designed to address a wide array of therapeutic areas, such as oncology, cardiology, gynecology, and infectious diseases.

Active Pharmaceutical Ingredients (APIs): The company produces a variety of active pharmaceutical ingredients that serve as the foundation for its formulations.

Biologics: The company actively involved in the development of biologics, which are innovative products derived from living organisms. This segment reflects the company's commitment to advancing healthcare through cutting-edge research and development, addressing unmet medical needs with novel therapeutic options.

Contract Manufacturing Services: The company offers contract manufacturing services to other pharmaceutical companies, leveraging its state-of-the-art facilities and expertise in production.

Research and Development Services: The company provides R&D services to support the development of new formulations and products. The company collaborates with other organizations to conduct research and clinical trials, contributing to the advancement of medical science.

Geographical Markets Served

The company has established a significant presence in various geographical markets, both domestically and internationally. The company's operations span multiple regions, allowing it to cater to a diverse customer base and address the healthcare needs of patients worldwide.

Customers

The company serves a diverse customer base that includes healthcare providers, hospitals, pharmacies, and patients.

Sales and Marketing

The company employs a multifaceted approach to marketing and distribution, ensuring that its products reach healthcare providers and patients effectively. The company utilizes a combination of direct sales, partnerships, and distribution agreements to expand its market presence.

The company engaged in various promotional activities, including medical conferences, seminars, and educational programs, to raise awareness of its product offerings. The company continuously evaluates and optimizes its distribution channels to enhance efficiency and meet the demands of the market.

Government Regulations

The company adheres to the guidelines set forth by regulatory authorities, including the U.S. Food and Drug Administration (USFDA) and the Securities and Exchange Board of India (SEBI). The company maintains robust quality control measures and conducts regular audits to ensure compliance with regulatory requirements.

History

Emcure Pharmaceuticals Limited was founded in 1981. The company was incorporated in 1981.

Emcure Pharmaceuticals Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Products:** 70% **Biotechnology:** 20% **Generics:** 10% **Top 3 Markets:** **India:** 50% **USA:** 30% **Europe:** 15% Emcure Pharmaceuticals Limited generates the majority of its revenue from the pharmaceutical industry, with a significant portion also coming from...

At which locations are the company’s products manufactured?

**Production Sites of Emcure Pharmaceuticals Limited:** Emcure Pharmaceuticals Limited mainly produces its products in India. The company has several production facilities in different parts of the country, including Pune, Jammu, and Ahmedabad. These sites are strategically chosen to efficiently s...

What strategy does Emcure Pharmaceuticals pursue for future growth?

**Revenue Growth:** Estimated at 10-12% annually (2026, based on industry comparison) **Research and Development Investments:** Increased by 15% (2025) Emcure Pharmaceuticals Limited is pursuing a growth strategy that heavily focuses on innovation and expansion into new markets. The company is incr...

Which raw materials are imported and from which countries?

**Main raw materials:** Active Pharmaceutical Ingredients (APIs), Excipients **Import countries:** China, India, USA, Europe Emcure Pharmaceuticals Limited mainly imports Active Pharmaceutical Ingredients (APIs) and excipients needed for the production of their pharmaceutical products. A significa...

How strong is the company’s competitive advantage?

**Market share in India:** 5.4% (2025) **Research and development ratio:** 7% of revenue (2025) **Export share of total revenue:** 30% (2025) Emcure Pharmaceuticals Limited has a significant competitive advantage due to its strong market presence in India, where it holds a market share of 5.4%....

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 45% (estimated for 2026) **Insider Purchases/Sales:** No significant transactions known (as of 2026) The institutional investor share in Emcure Pharmaceuticals Limited is estimated to be around 45%. This demonstrates a strong confidence from institutional investo...

What percentage market share does Emcure Pharmaceuticals have?

**Market share of Emcure Pharmaceuticals:** Estimated 3-4% (2026) **Top competitors and their market share:** 1. **Sun Pharmaceutical Industries:** 8-9% 2. **Cipla Limited:** 7-8% 3. **Dr. Reddy's Laboratories:** 6-7% 4. **Aurobindo Pharma:** 5-6% 5. **Lupin Limited:** 4-5% 6. **Emcure Pharmac...

Is Emcure Pharmaceuticals stock currently a good investment?

**Revenue Growth:** 10% (estimated for 2025) **Research and Development Investments:** 8% of revenue (2025) **Market Share in India:** 5% (2025) Emcure Pharmaceuticals Limited has experienced solid revenue growth of around 10% per year in recent years. This is attributed to expanding into internati...

Does Emcure Pharmaceuticals pay a dividend – and how reliable is the payout?

**Dividend payment:** No current data available (as of 2026) Emcure Pharmaceuticals Limited is an Indian pharmaceutical company specializing in the manufacturing and distribution of drugs. So far, there is no reliable information indicating that Emcure Pharmaceuticals regularly pays dividends to it...

New support ticket

Explore

Emcure Pharmaceuticals Stock Value

Emcure Pharmaceuticals Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Emcure Pharmaceuticals do?

Emcure Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Emcure Pharmaceuticals Stock Value

Emcure Pharmaceuticals Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Emcure Pharmaceuticals do?

Emcure Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.